alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) OF THE SECURITIES EXCHANGE
ACT OF 1934, AS AMENDED

I, William A. Mitchell, Jr., certify that:

     1.   I have reviewed this quarterly report on Form 10-Q of Front Range
          Capital Corporation;

     2.   Based on my knowledge, this quarterly report does not contain any
          untrue statement of a material fact or omit to state a material fact
          necessary to make the statements made, in light of the circumstances
          under which such statements were made, not misleading with respect to
          the period covered by this quarterly report;

     3.   Based on my knowledge, the financial statements, and other financial
          information included in this quarterly report, fairly present in all
          material respects the financial condition, results of operations and
          cash flows of the registrant as of, and for, the periods presented in
          this quarterly report;

     4.   The registrant's other certifying officer and I are responsible for
          establishing and maintaining disclosure controls and procedures (as
          defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
          registrant and we have:

          a.   Designed such disclosure controls and procedures, or caused such
               disclosure controls and procedures to be designed under our
               supervision, to ensure that material information relating to the
               registrant, including its consolidated subsidiaries, is made
               known to us by others within those entities, particularly during
               the period in which this quarterly report is being prepared;

          b.   Evaluated the effectiveness of the registrant's disclosure
               controls and procedures and presented in this report our
               conclusions about the effectiveness of the disclosure controls
               and procedures, as of the end of the period covered by this
               report based on such evaluation; and

          c.   Disclosed in this report any change in the registrant's internal
               control over financial reporting that occurred during the
               registrant's most recent fiscal quarter that has materially
               affected, or is reasonably likely to materially affect, the
               registrant's internal control over financial reporting.


Date: November 10, 2005                 /s/ William A. Mitchell, Jr.
                                        ----------------------------------------
                                        William A. Mitchell, Jr.
                                        Chief Executive Officer
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 14-7505

UNITED STATES OF AMERICA,

Plaintiff – Appellee,

v.

WILLIAM TURNER SMITH,

Defendant - Appellant.

Appeal from the United States District Court for the Eastern 

District of North Carolina, at Raleigh. James C. Dever III, 

Chief District Judge. (5:07-cr-00011-D-1; 5:14-cv-00373-D)

Submitted: March 24, 2015 Decided: April 15, 2015

Before KING, SHEDD, and FLOYD, Circuit Judges.

Dismissed by unpublished per curiam opinion.

William Turner Smith, Appellant Pro Se. Michael Gordon James, 

OFFICE OF THE UNITED STATES ATTORNEY, Raleigh, North Carolina, 

for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

William Turner Smith seeks to appeal the district court’s 

order dismissing his 28 U.S.C. § 2255 (2012) motion as 

successive. The order is not appealable unless a circuit 

justice or judge issues a certificate of appealability. 28 

U.S.C. § 2253(c)(1)(B) (2012). A certificate of appealability 

will not issue absent “a substantial showing of the denial of a 

constitutional right.” 28 U.S.C. § 2253(c)(2) (2012). When the 

district court denies relief on the merits, a prisoner satisfies 

this standard by demonstrating that reasonable jurists would 

find that the district court’s assessment of the constitutional 

claims is debatable or wrong. Slack v. McDaniel, 529 U.S. 473, 

484 (2000); see Miller-El v. Cockrell, 537 U.S. 322, 336-38 

(2003). When the district court denies relief on procedural 

grounds, the prisoner must demonstrate both that the dispositive 

procedural ruling is debatable, and that the motion states a 

debatable claim of the denial of a constitutional right. Slack, 

529 U.S. at 484-85. 

We have independently reviewed the record and conclude that 

Smith has not made the requisite showing. Accordingly, we deny 

a certificate of appealability and dismiss the appeal. We 

dispense with oral argument because the facts and legal 
3

contentions are adequately presented in the materials before 

this court and argument would not aid the decisional process.

DISMISSED
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7196 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7196

 To require the Comptroller General of the United States to conduct a 
study on the impacts of seasonal and nonresident homeownership on data 
     collected by the Bureau of the Census, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 1, 2024

  Mr. Edwards (for himself, Mr. Davis of North Carolina, Mr. Weber of 
 Texas, and Mr. Moore of Alabama) introduced the following bill; which 
     was referred to the Committee on Oversight and Accountability

_______________________________________________________________________

                                 A BILL

 
 To require the Comptroller General of the United States to conduct a 
study on the impacts of seasonal and nonresident homeownership on data 
     collected by the Bureau of the Census, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Federal Parity for Communities with 
Above Average Seasonal Homeownership Research Act'' or the ``Federal 
Parity for CASH Research Act''.

SEC. 2. STUDY ON IMPACTS OF SEASONAL AND NONRESIDENT HOMEOWNERSHIP ON 
              CENSUS DATA.

    (a) In General.--The Comptroller General of the United States 
shall, not later than 1 year after the date of the enactment of this 
section, conduct a study on--
            (1) the effect of homeownership in communities by seasonal 
        and non-permanent residents on the collection and accuracy of 
        data in censuses and surveys conducted by the Bureau of the 
        Census; and
            (2) the effect such data has on distribution of Federal 
        funding to such communities.
    (b) Special Focus.--In carrying out such study, the Comptroller 
General shall give special focus on rural Appalachia communities and 
coastal communities.
    (c) Recommendations.--If, in carrying out the study under 
subsection (a), the Comptroller General of the United State finds a 
negative effect between levels of seasonal and non-permanent resident 
homeownership and Federal funding distribution, the Comptroller General 
of the United States shall provide recommendations with respect to 
remedying such negative effect.
                                 <all>
```
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AND CONSOLIDATED STATEMENT OF OPERATIONS FOUND ON
PAGES 3 AND 4 OF THE COMPANY'S FORM 10-Q FOR THE YEAR TO DATE SEPTEMBER 30, 1998
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                           2,058
<SECURITIES>                                         0
<RECEIVABLES>                                    1,448
<ALLOWANCES>                                         0
<INVENTORY>                                        316
<CURRENT-ASSETS>                                   294
<PP&E>                                           7,927
<DEPRECIATION>                                 (6,199)
<TOTAL-ASSETS>                                  14,134
<CURRENT-LIABILITIES>                            9,272
<BONDS>                                              0
<PREFERRED-MANDATORY>                            2,898
<PREFERRED>                                          0
<COMMON>                                        61,297
<OTHER-SE>                                    (63,307)
<TOTAL-LIABILITY-AND-EQUITY>                    14,134
<SALES>                                          9,684
<TOTAL-REVENUES>                                 9,684
<CGS>                                            5,536
<TOTAL-COSTS>                                    5,536
<OTHER-EXPENSES>                                 1,779
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (492)
<INCOME-PRETAX>                                (5,449)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (5,449)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,449)
<EPS-PRIMARY>                                    (.60)
<EPS-DILUTED>                                    (.60)
        

</TABLE>
§ 507.115 Responsibilities of the receiving facility. ( a ) ( 1 ) The receiving facility must approve suppliers.
( 2 ) Except as provided by paragraphs (a)(3) and (4) of this section, the receiving facility must determine and conduct appropriate supplier verification activities, and satisfy all documentation requirements of this subpart.
( 3 ) An entity other than the receiving facility may do any of the following, provided that the receiving facility reviews and assesses the entity's applicable documentation, and documents that review and assessment: ( i ) Establish written procedures for receiving raw materials and other ingredients by the entity;
( ii ) Document that written procedures for receiving raw materials and other ingredients are being followed by the entity; and
( iii ) Determine, conduct, or both determine and conduct, the appropriate supplier verification activities, with appropriate documentation.
( 4 ) The supplier may conduct and document sampling and testing of raw materials and other ingredients, for the hazard controlled by the supplier, as a supplier verification activity for a particular lot of product and provide such documentation to the receiving facility, provided that the receiving facility reviews and assesses that documentation, and documents that review and assessment.
( b ) For the purposes of this subpart, a receiving facility may not accept any of the following as a supplier verification activity: ( 1 ) A determination by its supplier of the appropriate supplier verification activities for that supplier;
( 2 ) An audit conducted by its supplier;
( 3 ) A review by its supplier of that supplier's own relevant food safety records; or
( 4 ) The conduct by its supplier of other appropriate supplier verification activities for that supplier within the meaning of § 507.110(b)(4).
( c ) The requirements of this section do not prohibit a receiving facility from relying on an audit provided by its supplier when the audit of the supplier was conducted by a third-party qualified auditor in accordance with §§ 507.130(f) and 507.135.
§ 26.62 General obligations. ( a ) The United States shall, as specified in subparts A and B of this part, accept or recognize results of specified procedures, used in assessing conformity to specified legislative, regulatory, and administrative provisions of the United States, produced by the other party's conformity assessment bodies (CAB's) and/or authorities.
( b ) The European Community (EC) and its Member States shall, as specified in subparts A and B of this part, accept or recognize results of specified procedures, used in assessing conformity to specified legislative, regulatory, and administrative provisions of the EC and its Member States, produced by the other party's CAB's and/or authorities.
( c ) Where sectoral transition arrangements have been specified in subparts A and B of this part, the obligations in paragraphs (a) and (b) of this section will apply following the successful completion of those sectoral transition arrangements, with the understanding that the conformity assessment procedures utilized assure conformity to the satisfaction of the receiving party, with applicable legislative, regulatory, and administrative provisions of that party, equivalent to the assurance offered by the receiving party's own procedures.
#### § 515.23 Voluntary revocation of medicated feed mill license.

A license issued under section 512(m)(2) of the Federal Food, Drug, and Cosmetic Act (the act) will be revoked on the basis of a request for its revocation submitted in writing by a responsible individual holding such license on the grounds that the facility no longer manufactures any animal feed covered under § 558.4(b) of this chapter. A written request for such revocation shall be construed as a waiver of the opportunity for a hearing as otherwise provided for in this section. Revocation of approval of a medicated feed mill license under the provisions of this paragraph shall be without prejudice.
§ 382.10 What does this part do? This part requires that the award and administration of HHS grants and cooperative agreements comply with Office of Management and Budget (OMB) guidance implementing the portion of the Drug-Free Workplace Act of 1988 (41 U.S.C. 701-707, as amended, hereafter referred to as “the Act”) that applies to grants. It thereby— ( a ) Gives regulatory effect to the OMB guidance (Subparts A through F of 2 CFR part 182) for the HHS grants and cooperative agreements; and
( b ) Establishes HHS policies and procedures for compliance with the Act that are the same as those of other Federal agencies, in conformance with the requirement in 41 U.S.C. 705 for Governmentwide implementing regulations.
Exhibit 15.6





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





The Board of Directors


Dorad Energy Ltd.





We consent to the incorporation by reference in the registration statements (Nos. 333-187533, 333-102288 and 333-92491) on Form S-8 and (Nos. 333- 199696 and 333-144171) on Form F-3 of Ellomay Capital Ltd. of our report dated March 2 ,2016, with respect to the statements of financial position of Dorad Energy Ltd. as of December 31, 2015 and 2014 and the related statements of profit or loss, changes in equity and cash flows for each of the years in the three-year period ended December 31, 2015, which report appears in the December 31, 2015 annual report on Form 20-F of Ellomay Capital Ltd.





/s/Somekh Chaikin


Somekh Chaikin





Certified Public Accountants (Isr).


Member firm of KPMG International





Tel-Aviv, Israel





March 22, 2016
#### § 4.2 How does FDA define key terms and phrases in this subpart?

###### Cross Reference

Link to an amendment published at 89 FR 7522, Feb. 2, 2024.

###### Cross Reference

Link to an amendment published at 89 FR 51765, June 18, 2024.

The terms listed in this section have the following meanings for purposes of this subpart:

*Biological product* has the meaning set forth in § 3.2(d) of this chapter. A biological product also meets the definitions of either a drug or device as these terms are defined under this section.

*Combination product* has the meaning set forth in § 3.2(e) of this chapter.

*Constituent part* is a drug, device, or biological product that is part of a combination product.

*Co-packaged combination product* has the meaning set forth in § 3.2(e)(2) of this chapter.

*Current good manufacturing practice operating system* means the operating system within an establishment that is designed and implemented to address and meet the current good manufacturing practice requirements for a combination product.

*Current good manufacturing practice requirements* means the requirements set forth under § 4.3(a) through (d).

*Device* has the meaning set forth in § 3.2(f) of this chapter. A device that is a constituent part of a combination product is considered a finished device within the meaning of the QS regulation.

*Drug* has the meaning set forth in § 3.2(g) of this chapter. A drug that is a constituent part of a combination product is considered a drug product within the meaning of the drug CGMPs.

*Drug CGMPs* refers to the current good manufacturing practice regulations set forth in parts 210 and 211 of this chapter.

*HCT/Ps* refers to human cell, tissue, and cellular and tissue-based products, as defined in § 1271.3(d) of this chapter. An HCT/P that is not solely regulated under section 361 of the Public Health Service Act may be a constituent part of a combination product. Such an HCT/P is subject to part 1271 of this chapter and is also regulated as a drug, device, and/or biological product.

*Manufacture* includes, but is not limited to, designing, fabricating, assembling, filling, processing, testing, labeling, packaging, repackaging, holding, and storage.

*QS regulation* refers to the quality system regulation in part 820 of this chapter.

*Single-entity combination product* has the meaning set forth in § 3.2(e)(1) of this chapter.

*Type of constituent part* refers to the category of the constituent part, which can be either a biological product, a device, or a drug, as these terms are defined under this section.

[78 FR 4321, Jan. 22, 2013]
Office for Domestic Preparedness 

U.S. Department of Homeland Security 

Washington, DC 20531

ODP Information Bulletin 

No. 137 October 25, 2004 

TO All State Administrative Agency Heads 

 All State Administrative Agency Points of Contact 

 All State Homeland Security Directors 

FROM: C. Suzanne Mencer 

 Executive Director 

SUBJECT: Reaffirming ODP Policy for Reallocating Grant Funds 

Beginning in FY 2004, ODP permitted states and localities to reallocate grant funds across the 

following allowable spending categories without prior approval from ODP: 1) planning; 

2) equipment acquisitions; 3) training; 4) exercises; 5) management and administrative (M&A) 

costs. 

This decision to allow this type of reallocation of funds was made in order to provide grantees 

the flexibility to address emerging threats identified through assessments during the grant’s 

period of performance. Any reallocation of funds across those five categories must be consistent 

with state and urban area homeland security strategies. Furthermore, reallocations must be 

communicated to ODP through the required programmatic reports submitted throughout the life 

cycle of the grant (e.g., Initial Strategy Implementation Plans, Biannual Strategy Implementation 

Reports). 

States and urban areas are reminded that FY 2004 guidance states clearly that the transfer of 

funds among grant programs (e.g., State Homeland Security Program; Law Enforcement 

Terrorism Prevention Program; and Citizen Corps) is prohibited. 

These policies are supported and reaffirmed in appropriations language for the Department of 

Homeland Security in FY 2005. Grantees should anticipate similar provisions being included in 

FY 2005 grant program guidance.
[No. 16075-1-III.

Division Three.

January 8, 1998.]

#### J.G. Fox, Inc., *Appellant,*v. Victor S. Swanby, Jr., et al., *Respondents.*

Appeal from a judgment of the Superior Court for Spokane County, No. 93-2-01866-0, Kenneth H. Kato, J., entered August 19, 1996. *Affirmed*by unpublished opinion per Sweeney, J., concurred in by Kurtz, A.C.J., and Brown, J.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         321,995
<SECURITIES>                                    19,472
<RECEIVABLES>                                2,579,569
<ALLOWANCES>                                    64,166
<INVENTORY>                                  2,845,034
<CURRENT-ASSETS>                             6,310,286
<PP&E>                                      20,420,527
<DEPRECIATION>                               4,186,052
<TOTAL-ASSETS>                              22,782,262
<CURRENT-LIABILITIES>                        5,950,327
<BONDS>                                      7,447,206
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     4,860,207
<OTHER-SE>                                   4,415,024
<TOTAL-LIABILITY-AND-EQUITY>                22,782,262
<SALES>                                      7,735,279
<TOTAL-REVENUES>                             7,764,143
<CGS>                                        7,372,229
<TOTAL-COSTS>                                  660,138
<OTHER-EXPENSES>                                 3,743
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             201,057
<INCOME-PRETAX>                              (473,024)
<INCOME-TAX>                                 (188,000)
<INCOME-CONTINUING>                          (285,024)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (285,024)
<EPS-BASIC>                                      (.09)
<EPS-DILUTED>                                    (.09)


</TABLE>